Search Results 481-490 of 14962 for alt

  1. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Stage 3 Liver Fibrosis - Mayo Clinic

    ALT value > 5× the upper limit of normal (ULN) as defined by the central ... Evidence of significant worsening of ALT, AST or bilirubin during the ...

  2. T2 Lens Study - Mayo Clinic

    Significant renal dysfunction (eGFR < 45) or hepatic failure defined by elevated liver enzymes (AST above 36 U/L, ALT above 56 U/L). Participants with end ...

  3. A Study to Assess Dynamic Changes in Plasma Proteome to Identify Early Detection and Treatment Response Biomarkers for HGSOC - Mayo Clinic

    alanine aminotransferase (ALT)/ aspartate aminotransferase (AST)/ alkaline phosphatase < 2 x ULN. Exclusion Criteria: Patients who have received treatment ...

  4. Non-Alcoholic Fatty Liver Disease Progression Prevention Using Lisinopril - Mayo Clinic

    syndrome. - Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT) (serum glutamic pyruvic ...

  5. A Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard Medical Treatment - Mayo Clinic

    ... ALT, and/or total bilirubin ≥ 1.5xULN, and/or GGT ≥ 3 x ULN. Retesting is allowed once for abnormal LFT. Abnormal renal function defined as estimated ...

  6. Nesiritide in Resistant Hypertension - Mayo Clinic

    Total bilirubin of > 1.5 mg/dL or aspartate aminotransferase (AST) and alanine aminotransferase (ALT) 1.5 times the upper limit of normal range; Renal ...

  7. Assessing the Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes - Mayo Clinic

    Patients with NAFLD are eligible if their ALT level is ≤ 3.0 times the ULN. Current use of anticoagulation therapy (such as warfarin) that cannot be safely ...

  8. Study of SBP-101 in Pancreatic Cancer - Clinical Trials

    ... (ALT) ≤2.5 x upper limit of normal (ULN) (if no hepatic metastases). If hepatic tumor involvement, AST and ALT ≤5 x ULN, Bilirubin ≤1.5 x ULN ...

  9. IFX_HU2.0 As An Adjunctive Therapy To Pembrolixumab In Checkpoint Inhibitor Naive Subjects With Advanced Or Metastatic Merkel Cell Carcinoma - Mayo Clinic

    Serum Alanine Aminotransferase (ALT) ≤ 1 - 3 x ULN; Serum Aspartate Aminotransferase (AST) ≤ 1 - 3 x ULN; Alkaline Phosphatase (ALP) ≤ 1 - 2.5 x ULN; Gamma ...

  10. A Study to Evaluate T-DM1 With or Without Abemaciclib in Women and Men with HER2-positive Advanced or Metastatic Breast Cancer - Mayo Clinic

    NOTE: If liver metastases are present, AST and ALT ≤ 5 x ULN are acceptable. Prothrombin time (PT)/international normalized ratio (INR)/partial ...